ICD-10-CM Billable Code

F19.19

Other psychoactive substance abuse with unspecified psychoactive substance-induced disorder

Clinical Classification Guidelines

Medical Intelligence & Overview

The ICD-10 code F19.19 refers to a condition where a person abuses psychoactive substances, leading to a disorder triggered by an unspecified substance. Psychoactive substances influence the mind, affecting mood, perception, and behavior. When abuse of such substances causes mental health disturbances and the specific substance isn't identified, F19.19 is used for classification. Recognizing this diagnosis is vital for understanding the person's mental health and guiding suitable treatment strategies.

Causes & Symptoms

Clinical Causes: Use of psychoactive substances such as alcohol, opioids, stimulants, hallucinogens, or sedatives Repeated or excessive consumption leading to dependence or abuse Psychological factors like stress, mental health disorders, or social influences Trauma or significant life changes that trigger substance use Lack of access to appropriate mental health support or addiction treatment

Key Symptoms: Altered mental state, including confusion or hallucinations Changes in behavior, such as agitation or aggression Mood swings or emotional instability Physical signs like tremors, sweating, or dilated pupils Impaired judgment and coordination Possible episodes of psychosis or paranoia

Diagnostic & Treatment

Diagnosis Path: The diagnosis of F19.19 involves a comprehensive clinical evaluation, including a detailed history of substance use and mental health. Healthcare providers may use interviews, physical examinations, and psychological assessments to determine the presence of a substance-induced disorder. Since the specific psychoactive substance isn't identified in this code, clinicians focus on identifying the pattern of symptoms and behavioral changes consistent with substance abuse. Laboratory tests, such as blood or urine screens, can support diagnosis by detecting the presence of substances, although they might not specify the exact type when coded as unspecified.

Treatment Protocols: Treating a psychoactive substance abuse disorder with an unspecified substance involves a multidisciplinary approach, often including the following components: - **Detoxification:** Medical supervision to manage withdrawal symptoms safely. - **Counseling and psychotherapy:** Techniques such as cognitive-behavioral therapy (CBT) to address underlying issues and develop coping skills. - **Medication management:** In some cases, medications may be prescribed to reduce cravings or manage co-occurring mental health conditions. - **Support groups:** Participation in community or peer support programs can promote ongoing recovery. - **Lifestyle modifications:** Encouragement of healthy routines, regular exercise, and stress management. Effective treatment requires personalized plans addressing the individual's specific needs and circumstances, with ongoing support and monitoring to reduce relapse risks.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F19.19 a billable ICD-10 code?
Yes, F19.19 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F19.19?
Clinical documentation must specify the nature of Other psychoactive substance abuse with unspecified psychoactive substance-induced disorder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference